ArticleAbdominal radiology (New York)2022

Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.

Julaluck Promsorn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.